Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms-Reference-Cited by-同舟云学术

Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms

Published:2018-11-08 Issue:4 Volume:104 Page:e143-e146
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Halpern Anna B.,Othus Megan,Huebner Emily M.,Scott Bart L.,Hendrie Paul C.,Percival Mary-Elizabeth M.,Becker Pamela S.,Smith Heather A.,Oehler Vivian G.,Orozco Johnnie J.,Cassaday Ryan D.,Gardner Kelda M.,Chen Tara L.,Buckley Sarah A.,Orlowski Kaysey F.,Anwar Asma,Estey Elihu H.,Walter Roland B.

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intensive Reinduction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory High-Grade Myeloid Neoplasms;Transplantation and Cellular Therapy;2024-07

2. Venetoclax Combined with Intensive Chemotherapy: A New Hope for Refractory and/or Relapsed Acute Myeloid Leukemia?;Journal of Clinical Medicine;2024-01-18

3. Cladribine, cytarabine, and filgrastim based regimen in relapsed or refractory acute myeloid leukemia: A systematic review and meta-analysis;Medicine;2023-11-03

4. Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML;Blood Advances;2023-08-25

5. Effectiveness of chemotherapy using bortezomib combined with homoharringtonine and cytarabine in refractory or relapsed acute myeloid leukemia: a phase II, multicenter, prospective clinical trial;Frontiers in Oncology;2023-08-18